It is well accepted that cytotoxic lymphocytes specific for viruses (1) , haptens (2) , and minor histocompatibility antigens (HA) 1 (3, 4) recognize antigen in an H-2-restricted fashion during the effector phase. Precisely how the precursors of these cells respond to antigen during the induction phase, however, is poorly understood. In the case of skin graft rejection (5-9) and delayed-type hypersensitivity (10) to minor HA, mice can be primed with antigen presented on H-2-incompatible cells. Likewise, H-2 heterozygous mice primed with minor HA on cells of one parental strain develop cytolytic activity for target cells of both parental haplotyes (1 1, 12) . This effect of cross-priming suggests either that certain aspects of the response to minor HA are not H-2 restricted or, conversely, that the antigens are processed by host cells and then presented in association with host H-2 determinants in a restricted fashion (12) .
To attempt to clarify this question and, in particular, to gain information on the early stages of the cytotoxic T-cell response, we have studied the requirements for inducing negative and positive selection to minor HA in vivo. Previous work with this selection model has established that within 1 d of T-cell confrontation with such antigens as heterologous erythrocytes (13, 14) or foreign H-2 determinants (13-16) the responding T cells leave the circulation (undergo negative selection) and become selectively sequestered in the lymphoid tissues. Here, the cells proliferate extensively before reentering the circulation in expanded numbers after 2-3 d (positive selection). In the case ofT-helper cells for heterologous erythrocytes, T-cell selection appears not to involve a response to free antigen but rather to antigen that has been processed by macrophages or related cells (17) . The present studies suggest that, at least in certain situations, a similar requirement for antigen processing applies to the induction of cytotoxic lymphocytes specific for minor HA.
* Supported by grants AI-10961, AI-15393, and CA-15822 from the U. S. Public Health Service. i Abbreviations used in this paper." CML, cell-mediated lympholysis; HA, histocompatibility antigen (s); LU, lytic units; MR, maximum release of radioactivity; SR, spontaneous release; TDL, thoracic duct lymphocytes. Media. RPMI-1640 (Microbiological Associates, Walkersville, Md.) supplemented with 10% fetal calf serum, 10 -5 M 2-mercaptoethanol, and 40 /xg/ml Garamycin (Schering Corp., Kenilworth, N.J.) was used in all experiments.
Materials and Methods

Mice. CBA/J(H-2k), BIO.BR/SgSn(H-2k), C57BL/lOJ(H-2b)(BlO), BIO.D2(H-2 d) BIO.A(H-2a), and (BALB/c[H-2 ] X A/J[H-2
Preparation of Cells. Spleen cells were obtained by shearing the organs with a tissue grinder (Pyrex, Arthur H. Thomas Co., Philadelphia, Pa.) in cold medium. Clumps were removed by passage over cotton filters, and the suspended cells were washed twice by centrifugation. Cell viability was assessed by dye exclusion.
Injection. All cell suspensions were given intravenously in volumes of I ml unless stated otherwise.
Selection to minor HA. The technique used was essentially similar to that described previously for inducing selection to H-2 determinants (16). In brief, CBA mice were injected intravenously with large doses of spleen cells taken from normal syngeneic or minor HA-different allogeneic mice. To study negative selection, thoracic duct cannulae were inserted in the recipients ~ 18 h later and thoracic duct lymphocytes (TDL) were collected under sterile conditions between 22 and 40 h after spleen cell injection; other groups of mice were used to provide spleen and lymph node cells, these cells being harvested at 40 h after spleen-cell injection. For positive selection, the injected mice were cannulated at day 4 or 5 postinjection and TDL were collected overnight.
Priming to Minor HA In Vivo. All host mice used for selection were immunized intraperitoneally 3-6 wk before with 2 × 10 7 viable BI0.BR spleen cells.
Irradiation of Cells. Cells were exposed to 2,000 rad of 137Cs y-irradiation at a dose of 102 rad/min and then incubated at 37°C for 3-4"h (16) . The cells were then washed twice before injection. The viability of the injected cells was 70-80%. Treatment of Cells with Glutaraldehyde. Spleen cells were first resuspended in low ionic strength buffer and passaged over cotton filters to remove dead cells (18) . In a modification of the method of Bubbers and Henney (19) , cells were then washed once and resuspended at room temperature in 10 ml 0.002% glutaraldehyde (Electron Microscopy Sciences, Fort Washington, Pa.) diluted in buffered saline (pH 7.1). Fixation was stopped after 30 s by addition of 30 ml 0.15 M glyeine (diluted in buffered saline). The cells were then washed twice in cold 0.15 M glycine and resuspended to a final concentration of 120 × 106/ml for injection. Viability of the cells at the time of injection was -->96%.
Disruption of
Generation ofCytotoxic Lymphocytes In Vitro. Aliquots of 1-2 × 107 TDL were washed twice and placed in plastic tissue culture flasks (Corning Glass Works, Science Products Div., Corning, N.Y.) in 20 ml of medium and stimulated with 2 × 107 irradiated (1,200 rad) B10.BR, B10.K, or third-party H-2-different spleen cells. Cultures were incubated for 6 d at 37°C in 8% CO2. Cells were then harvested, washed twice, counted, and resuspended to appropriate concentrations for assaying cell-mediated lympholysis (CML).
Target Cells for CML. To prepare target cells, 4 × 106 lymph node cells were stimulated for 2-3 d with 2 ~tg/ml of concanavalin A (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) in 2-ml Linbro plates (Linbro Chemical Co., Hamden, Conn.). Blasts were labeled during the final 18 h with 20 ~Ci of 51Cr-sodium chromate (New England Nuclear, Boston, Mass.). After labeling, the cells were washed three times and resuspended to 2 × 105/ mt. CML Assay. In a modification of the method of Brunner et al. (20) , 100 ~1 of serially diluted effector cells together with 104 5aCr-labeled target cells in 50 #1 were placed in triplicate in Vbottom microtiter plates (Linbro Chemical Co.), centrifuged gently (400 rpm for 4 min), and then incubated for 5 h at 37°C. After centrifugation, 100/LI of the supernates were removed to measure radioactivity in an Intertechnique y-spectrometer. Maximum release of radioactivity (MR) and spontaneous release (SR) were determined with respect to radioactive counts released after incubation with centrimide-saline and medium, respectively; SR ranged from 15 to 35% of MR. The percent specific lysis was calculated by the formula: (experimental release -SR/ MR -SR) X 100; CML obtained on the syngenic CBA targets was invariably <7%.
Calculation of Lytic Units of CML Activity. To compare the relative levels of CML in the experimental groups vs. the control group, lytic units (LU) of CML activity were calculated by a modification of the method of Cerottini and Brunner (21) . LU were defined arbitrarily in terms of the number of effector cells required to exert 25% CML (LU 25%). LU 25% were calculated from dose-response linear regression lines plotted with respect to CML observed with three different killer:target ratios; correlation coefficients for linearity were generally >0.95. The lytic activity of each experimental group of effector cells compared with the control group was calculated by the formula: (LU 25% control/LU 25% experimental) X 100.
Results
Experimental Design. The basic aim was to examine the requirements for inducing CBA(H-2 k) T cells to exert cytotoxic responses against the multiple minor HA on H-2-compatible B 10.BR target cells (CBA and B 10.BR differ at a minimum of six minor HA loci [22] ). To study selection to these antigens, CBA mice were injected intravenously with large doses of spleen cells tape from mice of the B 10 congenic lines, e.g., B10.BR, B10(H-2b), or B10.D2(H-2d); these strains all express the same minor HA foreign to CBA but have differing H-2 haplotypes. TDL, spleen, or lymph node cells were harvested from the recipients at day 1 (negative selection) or day 5 (positive selection) posttransfer and cultured in vitro for 6 d with H-2-compatible B 10.BR or B 10.K stimulator cells; these stimulators were used irrespective of the H-2 haplotype of the cells used to produce selection. CML (~lCr release) was then tested on a variety of target cells.
Preliminary studies established that the effector cells in the CBA anti-B10.BR CML responses were T (Thy-l.2-positive) cells (data not shown). Because primary CML responses to minor HA in vitro are very low, the CBA TDL donors were primed with B10.BR spleen cells 3-6 wk before inducing selection. At this time, TDL from the primed donors were not directly cytotoxic even at high (300:1) killer:target cell ratios (data not shown) and hence were probably typical circulating memory cells.
To facilitate comparison of levels of cytotoxic activity, the data in most of the tables are shown first in terms of specific 51Cr release observed with different killer:target cell ratios, and second as the percent lytic activity established with respect to the control cells, i.e., cells from CBA mice preinjected with syngeneic spleen cells (Materials and Methods).
Specificity of the CML Response of CBA T Cells Cultured with BIO.BR Stimulators: Genetic
Mapping Studies. Before studying selection it was first necessary to prove that the CBA anti-B10.BR CML response was indeed H-2 restricted, i.e., as reported for other anti-minor HA responses (3, 4) .
The cytolytic activity of unselected CBA TDL (TDL from recipients of syngeneic spleen cells) cultured in vitro with B10.BR stimulators is shown in the left-hand column of Table I . As expected, CML was high with the stimulating population (B10.BR) and the closely related strain, B10.K, but was not detectable with three H-2-different target cells that expressed the minor HA of BI0.BR, i.e., B10, B10.D2, and
B IO.Q(H-2q).
Although these data implied that CML was H-2 restricted, good killing was surprisingly observed with B 10.T(6R) (d) targets, i.e., cells lacking the H-2 h alleles of the CBA responders. Moreover, CML was also apparent against two strains possessing H-2 k alleles only in the I region, i.e., B10.S(9R) (ssskkddd) and B104.AQR (qkkkkddd) ( this strain. It is evident that this procedure virtually abolished the anomalous lysis against B10.T(6R), B 10.S(9R) and B 104.AQR target cells but only marginally affected lysis of other targets. However, the point to be emphasized is that the specificity of CML was now in accord with the results of other workers (3, 4), i.e., CML to the minor HA of the stimulator strain was restricted to target cells that were compatible with the responder strain at either the K-or D-end of the H-2 complex. There was no lysis of target cells that were H-2 compatible only in the I region.
The data in Table I imply that CML to Qa-1 a determinants would be avoided if B10.K (Qa-l~ cells rather than B10.BR cells were used as stimulators. This was indeed the case, i.e., in other experiments (data not shown), the CML specificity of CBA TDL stimulated with B 10.K cells was virtually identical to that seen in Table  I with CBA-c^v, TDL cultured with B10.BR cells. Hence to prevent the complication of generating anti-Qa-1 a activity, 2 most of the experiments to be considered below employed B10.K cells as stimulators and/or target cells. B10.K mice were in short supply and hence could not be used in all experiments. All of the experiments in the tables below were repeated at least once and normally 2-3 times.
Negative Selection to Minor HA Induced with Irradiated H-2-Compatible Spleen Cells. To induce selection, CBA mice were injected intravenously with large doses of CBA or 2 It is worth mentioning that the anti-Q a-1 CML apparent in Table I tended to be variable in magnitude and on occasions was virtually undetectable (Table III, Table  II .
In other experiments, CML tested on B10.K target cells gave similar results. § See Table II. [1 Not done. ¶ According to the data presented in Table I, Table II . It can be seen that TDL from CBA mice given B10.BR spleen cells in large doses 1 d before were unable to generate CML against B10.BR targets. Selection was specific because stimulation of the TDL with third-party H-2-different cells gave high levels of lysis (Table II, footnote; and later tables). The extent of selection against B 10.BR was dose dependent: 2 × l0 s and l0 s cells usually caused near-complete unresponsiveness, whereas selection was minimal with smaller cell doses.
In contrast to the unresponsiveness of TDL, spleen cells taken at 1 d after B10.BR spleen cell injection contained normal or enriched numbers of B10.BR-reactive cells Table II. § Not done.
( Table II) . With lymph node cells the response was either unchanged or moderately reduced. When TDL were harvested at 5 d posttransfer rather than at day 1, anti-B 10.BR responses were usually enhanced. Collectively, these data imply that, as with other antigens, T cells that encounter minor HA in vivo rapidly become sequestered in the lymphoid tissues, particularly in the spleen, and then reenter the circulation several days later after clonal expansion.
Negative Selection with Irradiated H-2-Incompatible Spleen Cells. Further studies showed that the H-2 haplotype of the minor HA-bearing spleen cells given to the donors of CBA TDL had no apparent effect on the degree of selection to B10.BR minor HA determinants. Thus, irrespective of whether the injected spleen cells were H-2 compatible (B10.BR) or H-2 different (B10 or B10.D2) with respect to the responding T cells, reactivity to B10.BR targets (Table III) or B 10.K targets (data not shown) was virtually undetectable; again, responsiveness to third-party antigens was unimpaired (Table III) .
Negative Selection with Disrupted Spleen Cells. Because heavily irradiated cells die within a few hours of injection (29) , the above data raised the possibility that antigen selection was initiated not by intact cells but by cell fragments. According to this possibility, disrupting the spleen cells before injection would not impair selection. Indeed, as shown in Table IV Table  II) . With H-2-different B10, BI0.D2, or B10.Q cells, by contrast, glutaraldehyde treatment almost completely abolished selection, i.e., TDL from mice preinjected with these cells generated near-normal levels of CML against either B10.K targets (Table  V) or B10.BR targets (data not shown).
Although H-2-different glutaraldehyde-treated cells failed to induce negative selection to minor HA, injection of these cells did lead to effective selection against the H-2 determinants on the cells. For example, when CBA TDL from recipients of glutaraldehyde-treated B lO.D2(H-2 u) cells were stimulated in vitro with (BALB/c × B6)Fx(H-2 a × H-2~ ceils, CML was low or absent against BI0.D2 targets but was high against the third-party B 10(H-2 t') targets (Table V) . Table V .
Negative Selection with Glutaraldehyde-treated Cells from H-2 Recombinant
Mice. To attempt to map the apparent H-2 restriction of selection observed with glutaraldehyde-treated cells, selection was studied in CBA mice given glutaraldehyde-treated cells from mice of the B10 recombinant strains. When B10.OL (ddddddkk) cells were used for selection, culture of the recipient CBA TDL with B10.K stimulators led to effective lysis against B10.A (kkkkkddd) targets but not against B10.OL targets (Table  VI) . These data implied that selection affected T cells specific for determinants mapping in the D-end of the H-2 complex but did not involve K-end-specific T cells. Reciprocal findings were expected when B 10.A cells were used for selection. Curiously, however, this was not the case: Selection with B 10.A cells led to unresponsiveness not only against B 10.A targets but also against B I0.OL targets, i.e., as for selection with (B10.A × B10.OL)F1 cells. Identical findings applied to selection with B104.AQR (qkkkkddd) cells, i.e., cells that were H-2 compatible with the host only in the I region. Three other experiments gave comparable findings. In two of these experiments, as a specificity control, the cells selected against B 10.A and B 104.AQR cells were tested for their capacity to generate CML against third-party H-2 b target cells. High levels of lysis were obtained (data not shown).
Discussion
Most of the evidence on cross-priming to minor HA has come from studies on the long-term effects of immunizing mice with H-2-different cells. Our findings that negative selection to minor HA can be induced with irradiated or disrupted H-2-different cells implies that cross-priming can occur very rapidly, i.e., within 1 d. As with other examples of cross-priming, these data per se might either reflect processing of antigen by host cells (thus enabling the antigen to become associated with self H-2 determinants) or alternatively signify a lack of H-2 restriction during T-cell induction. The experiments on the effects of using glutaraldehyde-treated cells for selection were designed to discriminate between these two possibilities.
The rationale here was that if cross-priming resulted from antigen processing, treatment of the antigen-bearing cells with a fixative such as glutaraldehyde might interfere with this phenomenon and thereby impair the capacity of the cells to induce selection across H-2 barriers. Indeed, testing this prediction showed that negative selection to minor HA induced by H-2-different cells was low or undetectable when the cells were treated briefly with low concentrations of glutaraldehyde before injection. Significantly, glutaraldehyde treatment did not affect selection in H-2-compatible situations, i.e., in contrast to irradiated or sonicated cells, selection with glutaraldehyde-treated cells was H-2 restricted.
In interpreting these data it should first be stressed that the precise mechanism of action of glutaraldehyde treatment in the selection assay is unknown. Because glutaraldehyde cross-links proteins (30) , our working hypothesis is that treatment with this reagent retards destruction of the antigen-bearing cells and/or interferes with antigen processing by host cells, e.g., by somehow preventing moieties of antigen from forming an immunogenic association with host H-2 determinants. Although this is largely speculation it is difficult to offer an alternative explanation that fits the data. The fact that glutaraldehyde-treated cells remained immunogenic in H-2-compatible situations makes it unlikely that the antigenicity of the minor HA on the selecting cells was impaired. Likewise, the H-2 determinants on the cells seemed to remain intact because effective selection was observed against the H-2 determinants on glutaraldehyde-treated cells (Table V) . Indeed there appears to be general agreement in the literature that glutaraldehyde treatment does not denature cell surface components (19, 31, 32) , at least under the mild conditions used in this study. It may also be mentioned that in our hands glutaraldehyde treatment does not prevent long-term cross-priming, i.e., CBA mice injected several weeks before with glutaraldehydetreated B10.D2 spleen cells give typical secondary responses to B10.K cells in vitro (R. Korngold and J. Sprent. Unpublished data.).
Whatever the exact consequences of treating cells with glutaraldehyde, the fact that selection to minor HA was H-2 restricted would seem to exclude the possibility that selection reflected an H-2-unrestricted response to antigen. 3 Can one conclude therefore that cytotoxic T-cell induction depends upon some form of antigen processing? In the case of cross-priming (presentation of antigen on H-2-different cells), the data on the immunogenicity of irradiated and disrupted cells vs. glutaraldehyde-treated cells in the selection assay are strongly in favor of this viewpoint. The precise mechanism of induction to minor HA, however, is far from clear. Because the specificity of the effector cells was directed to K-and D-end H-2 determinants (Table  I) , it is tempting to extrapolate from the induction of I region-restricted T cells involved in T-B collaboration and argue that cytotoxic precursor cells are triggered by contact with antigen that becomes associated with K/D determinants on macrophages or related cells. Although appealing from the point of view of symmetry, this notion has to be viewed with caution for the following reasons: (a) The recent evidence that I region-restricted T-helper cells control responses to minor HA (33-36) adds a new dimension to the problem of cytotoxic T-cell induction and implies that, in addition to K/D determinants, the antigen-presenting cells might also have to express Ia determinants. (b) There is no direct evidence that macrophages or accessory cells play other than a nonspecific role in cytotoxic T-cell induction in vitro (37) . For in Although primed mice were used in these experiments, recent studies in which unprimed T cells were primed to antigen on adoptive transfer after selection to glutaraldehyde-treated cells have given similar findings.
vivo responses, the only direct evidence that a specific class of antigen-presenting cells is required for CML induction is the finding of Zinkernagel et al. (38) that H-2-compatible cells of bone marrow origin are needed for generating CML to virusinfected cells; whether these cells belong to the macrophage lineage is unknown. (c) If typical macrophages do control antigen presentation, it remains to be explained why cross-priming is easily demonstrable in vivo but not in vitro (12) . For these reasons the case that cytotoxic T-cell induction is simply a reflection of T-macrophage interaction and closely resembles the induction of T cells involved in T-B collaboration is far from being proved.
The conclusion that antigen processing is a prerequisite for inducing responses to minor HA across H-2 barriers does not necessarily imply that processing is mandatory in H-2-compatible situations. Indeed the argument that glutaraldehyde treatment impairs antigen processing rests on the assumption that the selection to minor HA observed with H-2-compatible glutaraldehyde-treated cells reflects a response to the injected cells per se. This latter finding was predictable because virtually all of the injected spleen cells presumably expressed the requisite combination of minor HA plus self K/D determinants. Nevertheless it is conceivable that, even in this situation, the capacity to present antigen is unique to a particular class of cells. This question is currently under investigation.
Finally, comment should be made on the paradoxical effects of inducing selection with glutaraldehyde-treated cells from mice of the B 10 recombinant strains. Because there is general agreement that H-2K-and H-2D-restricted CML is mediated by distinct subgroups of T cells, the expectation was that these subgroups could be separated by inducing selection with minor HA-bearing cells that were compatible In interpreting these data it may be relevant that in the case of B10.A cells, the cells used for selection shared Ia antigens with the host. Hence, negative selection with B 10.A cells might remove not only K-end-restricted cytotoxic precursors but also I region-restricted T-helper cells critical for facilitating differentiation in vitro of the unsetected D-end-restricted cells (36) . Accordingly, selection with cells that were H-2 compatible with the host only in the I region would be expected to have a similar effect. This was indeed found to be the case, i.e., selection of CBA mice with glutaraldehyde-treated B104.AQR (qkkkkddd) cells led to marked unresponsiveness against both B10.A and B10.OL targets (Table VI) .
Which particular H-2Isubregion(s) must be matched to obtain selection is currently under investigation. Preliminary studies have shown unexpectedly that selection of the CBA anti-B10.K response can be induced with either B10.A(4R) (kkbbbbbb) cells or B10.HTT (sssskkkd) cells, i.e., cells that are H-2I compatible with the host only at the I-A and I-E/C subregions, respectively. Such findings are not easily interpreted.
Proving the participation of I region-restricted T-helper ceils in this system, however, will require demonstrating that addition of these cells in culture can reconstitute the cytotoxic activity of the supposedly T-helper cell-deficient selected T cells. Such studies are in progress.
Summary
Intravenous injection of CBA mice with H-2-compatible irradiated B10.BR spleen cells led to a sequence of negative and positive selection of the host T-cell response against the multiple foreign minor histocompatibility antigens (HA) on the injected cells. By 1 d posttransfer, thoracic duct lymphocytes (TDL) of the host had lost the capacity to differentiate in vitro into cytotoxic cells specific for the injected minor HA; spleen and lymph node cells, by contrast, gave normal or enriched responses at this time. By 5 d posttransfer, TDL were hyperresponsive to the injected antigens. Selection with disrupted (sonicated) cells gave similar findings.
With injection of either irradiated or disrupted spleen cells, the H-2 haplotype of the minor HA-bearing cells had no apparent effect on the magnitude of selection. By contrast, treatment of spleen cells with glutaraldehyde before injection led to H-2 restriction of selection, i.e., negative selection of the CBA response to B10.BR was marked with injection of glutaraldehyde-treated H-2-compatible B10.BR cells but was minimal with H-2-different B10 or B 10.D2 cells. These data are taken to imply that, at least in H-2-incompatible situations, the minor HA-bearing cells must be processed by host cells, i.e., to allow the antigens to become associated with self H-2 determinants.
Circumstantial evidence from studies on the specificity of selection induced with glutaraldehyde-treated cells from mice of the B 10 recombinant strains suggested that I region-restricted T cells may control the induction of H-2K, D-restricted cytotoxic precursor cells.
